UA105185C2 - Піроли - Google Patents

Піроли

Info

Publication number
UA105185C2
UA105185C2 UAA201103600A UAA201103600A UA105185C2 UA 105185 C2 UA105185 C2 UA 105185C2 UA A201103600 A UAA201103600 A UA A201103600A UA A201103600 A UAA201103600 A UA A201103600A UA 105185 C2 UA105185 C2 UA 105185C2
Authority
UA
Ukraine
Prior art keywords
halogen
optionally substituted
group optionally
alkyl group
hydrogen atom
Prior art date
Application number
UAA201103600A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Харуюкі Нішіда
Ясуйоші Арікава
Ікуо Фуджіморі
Original Assignee
Такеда Фармасьютікал Компані Лімітед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41508823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA105185(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Такеда Фармасьютікал Компані Лімітед filed Critical Такеда Фармасьютікал Компані Лімітед
Publication of UA105185C2 publication Critical patent/UA105185C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
UAA201103600A 2008-08-27 2009-08-26 Піроли UA105185C2 (uk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008218851 2008-08-27
JP2008269099 2008-10-17
PCT/JP2009/065279 WO2010024451A1 (en) 2008-08-27 2009-08-26 Pyrrole compounds

Publications (1)

Publication Number Publication Date
UA105185C2 true UA105185C2 (uk) 2014-04-25

Family

ID=41508823

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201103600A UA105185C2 (uk) 2008-08-27 2009-08-26 Піроли

Country Status (38)

Country Link
US (3) US8592597B2 (enExample)
EP (1) EP2318390B1 (enExample)
JP (1) JP5638515B2 (enExample)
KR (1) KR101629181B1 (enExample)
CN (1) CN102197033B (enExample)
AR (1) AR073136A1 (enExample)
AU (1) AU2009284867B2 (enExample)
BR (1) BRPI0917705A2 (enExample)
CA (1) CA2735162C (enExample)
CL (1) CL2011000402A1 (enExample)
CO (1) CO6321166A2 (enExample)
CR (1) CR20110169A (enExample)
CY (1) CY1114452T1 (enExample)
DK (1) DK2318390T3 (enExample)
DO (1) DOP2011000061A (enExample)
EA (1) EA019741B1 (enExample)
EC (1) ECSP11010912A (enExample)
ES (1) ES2423289T3 (enExample)
GE (1) GEP20135786B (enExample)
HR (1) HRP20130653T1 (enExample)
IL (1) IL211335A (enExample)
JO (1) JO2871B1 (enExample)
MA (1) MA32647B1 (enExample)
ME (1) ME01598B (enExample)
MX (1) MX2011001955A (enExample)
MY (1) MY152008A (enExample)
NZ (1) NZ591793A (enExample)
PE (2) PE20141174A1 (enExample)
PL (1) PL2318390T3 (enExample)
PT (1) PT2318390E (enExample)
RS (1) RS52872B (enExample)
SI (1) SI2318390T1 (enExample)
SM (1) SMT201300085B (enExample)
TW (1) TWI473798B (enExample)
UA (1) UA105185C2 (enExample)
UY (1) UY32074A (enExample)
WO (1) WO2010024451A1 (enExample)
ZA (1) ZA201101774B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5638515B2 (ja) * 2008-08-27 2014-12-10 武田薬品工業株式会社 ピロール化合物
US20110229879A1 (en) * 2010-03-19 2011-09-22 University Of Rochester Methods and compositions for nuclear staining
CN102452979B (zh) * 2010-11-03 2015-04-01 天津药明康德新药开发有限公司 5-氟-3-吡啶磺酰氯的合成方法
CN102863371B (zh) * 2011-07-06 2016-04-13 中国科学院上海有机化学研究所 氟代二氢吡咯或氟代吡咯
WO2013119800A1 (en) 2012-02-07 2013-08-15 Massachusetts Institute Of Technology Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
MX2014015269A (es) 2012-06-27 2015-02-20 Takeda Pharmaceutical Preparaciones liquidas de aminas y acidos organicos estabilizados por sales.
EP2963019B1 (en) 2013-02-28 2020-08-12 Takeda Pharmaceutical Company Limited Method for producing pyridine-3-sulfonyl chloride
WO2014144231A1 (en) 2013-03-15 2014-09-18 Massachusetts Institute Of Technology Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
KR102084185B1 (ko) 2013-08-29 2020-03-04 주식회사 대웅제약 테트라히드로사이클로펜타피롤 유도체 및 이의 제조방법
CN105367550A (zh) * 2014-08-11 2016-03-02 江苏柯菲平医药股份有限公司 四氢环戊二烯并[c]吡咯类衍生物、其制备方法及其在医药上的应用
UY36547A (es) 2015-02-05 2016-06-01 Bayer Cropscience Ag Derivados heterocíclicos condensados bicíclicos sustituidos por 2-(het)arilo como pesticidas
US10317418B2 (en) 2015-02-24 2019-06-11 Massachusetts Institute Of Technology Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
SG10201914087UA (en) 2015-07-30 2020-03-30 Takeda Pharmaceuticals Co Tablet
CN118955472A (zh) 2015-08-07 2024-11-15 拜耳作物科学股份公司 作为农药的2-(杂)芳基取代的稠合杂环衍生物
CN106430006B (zh) * 2016-08-18 2018-06-12 国网湖南省电力公司带电作业中心 配电线路移动式绝缘登高作业装置及方法
CN108203430A (zh) * 2016-12-16 2018-06-26 天地人和生物科技有限公司 一种新型可逆性质子泵抑制剂及其制备方法和用途
ES2921931T3 (es) 2017-07-10 2022-09-02 Takeda Pharmaceuticals Co Preparación que comprende vonoprazán
KR102126576B1 (ko) 2018-09-19 2020-06-24 주식회사 대웅제약 4-메톡시 피롤 유도체의 제조 방법
CN113527536B (zh) * 2020-04-21 2024-03-22 杭州德柯医疗科技有限公司 一种含氟多糖高分子化合物及其制备方法
US11767311B2 (en) * 2020-06-17 2023-09-26 Ildong Pharmaceutical Co., Ltd. Acid secretion inhibitor and use thereof
EP4074317A1 (en) 2021-04-14 2022-10-19 Bayer AG Phosphorus derivatives as novel sos1 inhibitors
CN113620930B (zh) * 2021-07-12 2022-08-16 南京烁慧医药科技有限公司 一种含磺酰胺结构的化合物及其制备方法和应用、一种药物组合物及应用
US20250084026A1 (en) * 2021-12-15 2025-03-13 Ildong Pharmaceutical Co., Ltd. Novel salt of 1-sulfonyl pyrrole derivative, preparation method thereof and pharmaceutical composition comprising thereof
CN118541361A (zh) * 2021-12-15 2024-08-23 日东制药株式会社 1-磺酰基吡咯衍生物的新型盐、其制备方法和包括其的药物组合物
KR20230102353A (ko) * 2021-12-30 2023-07-07 주식회사 대웅제약 삼중음성유방암의 예방 또는 치료용 약학적 조성물

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2031514T3 (es) 1986-08-29 1992-12-16 Pfizer Inc. 2-guanidino-4-ariltiazoles para el tratamiento de ulceras pepticas.
US5128366A (en) 1990-07-05 1992-07-07 Shinogi & Co., Ltd. Pyrrole derivatives
US5331006A (en) * 1990-08-31 1994-07-19 Warner-Lambert Company Amino acid analogs as CCK antagonists
WO1992004025A1 (en) 1990-08-31 1992-03-19 Warner-Lambert Company Amino acid analogs as cck antagonists
AU664392B2 (en) 1991-10-18 1995-11-16 Monsanto Technology Llc Fungicides for the control of take-all disease of plants
CN1071924A (zh) 1991-10-29 1993-05-12 纳幕尔杜邦公司 除草的三唑羧酸酰胺
JPH06135961A (ja) 1992-10-23 1994-05-17 Nippon Iyakuhin Kogyo Kk 新規ジフェニルピロリルフラン誘導体
US5286742A (en) * 1992-11-03 1994-02-15 American Cyanamid Company Pyrrole thiocarboxamide insecticidal and acaricidal agents
US5480902A (en) * 1993-08-31 1996-01-02 American Cyanamid Company Thienylpyrrole fungicidal agents
JPH08119936A (ja) 1994-10-18 1996-05-14 Fujisawa Pharmaceut Co Ltd 複素環式誘導体
JPH0930967A (ja) 1995-07-17 1997-02-04 Chugai Pharmaceut Co Ltd 抗潰瘍剤
NZ334256A (en) 1996-08-28 2000-11-24 Procter & Gamble 1-substituted sulphonyl-pyrrolidine derivatives useful as metalloprotease inhibitors
IL130286A0 (en) 1996-12-23 2000-06-01 Du Pont Pharm Co Nitrogen containing heteroaromatics as factor Xa inhibitors
JPH11209344A (ja) 1998-01-26 1999-08-03 Kyowa Hakko Kogyo Co Ltd 含窒素複素環化合物
GB9817548D0 (en) 1998-08-12 1998-10-07 Novartis Ag Organic compounds
ATE295831T1 (de) 1999-03-10 2005-06-15 Shionogi & Co Medizinische zubereitungen mit (2.2.1) und (3.1.1)bicycloskelett die antagonisten für sowohl pgd 2? als auch txa 2? rezeptoren sind
TW575561B (en) 1999-03-25 2004-02-11 Hoffmann La Roche 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives
AU3783100A (en) 1999-06-14 2000-12-21 Dow Agrosciences Llc Substituted triazoles, imidazoles and pyrazoles as herbicides
ATE309995T1 (de) * 1999-08-26 2005-12-15 Aventis Pharma Inc Substituierte (aminoiminomethyl oder aminomethyl) dihydrobenzofurane und benozopyrane
US6911468B2 (en) 2000-05-22 2005-06-28 Takeda Chemical Industries, Ltd. Tyrosine phosphatase inhibitors
US6589978B2 (en) 2000-06-30 2003-07-08 Hoffman-La Roche Inc. 1-sulfonyl pyrrolidine derivatives
GB0016453D0 (en) 2000-07-04 2000-08-23 Hoffmann La Roche Pyrrole derivatives
CA2460594A1 (en) 2001-10-01 2003-04-10 Taisho Pharmaceutical Co., Ltd. Mch receptor antagonists
MXPA04004464A (es) 2001-11-08 2004-08-11 Upjohn Co Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
AU2002342909A1 (en) 2001-11-22 2003-06-10 Ciba Specialty Chemicals Holding Inc. Pyrrole synthesis
AU2002367424A1 (en) 2001-12-28 2003-07-24 Takeda Chemical Industries, Ltd. Androgen receptor antagonists
WO2003068738A1 (en) 2002-02-11 2003-08-21 Neurocrine Biosciences, Inc. Pyrrole derivatives as ligands of melanocortin receptors
AU2003209114A1 (en) 2002-02-14 2003-09-04 Wyeth Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
TW200306191A (en) 2002-02-22 2003-11-16 Teijin Ltd Pyrrolopyrimidine derivatives
US7754738B2 (en) 2002-06-13 2010-07-13 E.I. Du Pont De Nemours And Company Pyrazole and pyrrole carboxamide insecticides
CA2495216A1 (en) 2002-08-12 2004-02-19 Sugen, Inc. 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
JP2004315511A (ja) 2003-03-31 2004-11-11 Taisho Pharmaceut Co Ltd Ｍｃｈ受容体アンタゴニスト
JP4716996B2 (ja) 2003-05-26 2011-07-06 武田薬品工業株式会社 スルホピロール
JP5173192B2 (ja) * 2004-09-30 2013-03-27 武田薬品工業株式会社 プロトンポンプ阻害薬
EP1655284A1 (en) 2004-10-26 2006-05-10 Aponetics AG 2-Phenylsulfopyrroles
KR101408561B1 (ko) * 2005-08-30 2014-06-19 다케다 야쿠힌 고교 가부시키가이샤 산 분비 억제제로서 1-헤테로시클릴술포닐, 2-아미노메틸, 5-(헤테로-) 아릴 치환된 1-ｈ-피롤 유도체
US8512761B2 (en) 2006-01-27 2013-08-20 Yale University Fast acting inhibitor of gastric acid secretion
CA2647862A1 (en) 2006-03-31 2007-10-11 Takeda Pharmaceutical Company Limited Acid secretion inhibitor
US8933105B2 (en) 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
US20090156642A1 (en) 2007-09-28 2009-06-18 Takeda Pharmaceutical Company Limited 5-Membered heterocyclic compound
US20090318429A1 (en) * 2008-04-28 2009-12-24 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Heteroaromatic Derivatives
CN102105451B (zh) 2008-05-16 2013-11-13 塔克达加利福尼亚股份有限公司 葡糖激酶活化剂
JP5638515B2 (ja) * 2008-08-27 2014-12-10 武田薬品工業株式会社 ピロール化合物

Also Published As

Publication number Publication date
EP2318390A1 (en) 2011-05-11
US20140031393A1 (en) 2014-01-30
US8592597B2 (en) 2013-11-26
JP2012501296A (ja) 2012-01-19
PE20141174A1 (es) 2014-09-19
US20110172275A1 (en) 2011-07-14
MX2011001955A (es) 2011-03-29
US8993598B2 (en) 2015-03-31
EA201170384A1 (ru) 2011-10-31
ECSP11010912A (es) 2011-04-29
SI2318390T1 (sl) 2013-08-30
HK1157756A1 (en) 2012-07-06
EP2318390B1 (en) 2013-05-01
WO2010024451A1 (en) 2010-03-04
KR101629181B1 (ko) 2016-06-13
PT2318390E (pt) 2013-07-10
KR20110071067A (ko) 2011-06-28
AR073136A1 (es) 2010-10-13
UY32074A (es) 2010-03-26
IL211335A0 (en) 2011-04-28
JO2871B1 (en) 2015-03-15
JP5638515B2 (ja) 2014-12-10
ES2423289T3 (es) 2013-09-19
MY152008A (en) 2014-08-15
ZA201101774B (en) 2012-06-27
CO6321166A2 (es) 2011-09-20
US8969387B2 (en) 2015-03-03
SMT201300085B (it) 2013-09-06
DOP2011000061A (es) 2011-04-15
HRP20130653T1 (en) 2013-08-31
CR20110169A (es) 2011-05-16
MA32647B1 (fr) 2011-09-01
PL2318390T3 (pl) 2013-09-30
AU2009284867B2 (en) 2014-08-28
CY1114452T1 (el) 2016-10-05
EA019741B1 (ru) 2014-05-30
NZ591793A (en) 2012-11-30
CN102197033B (zh) 2014-07-16
US20100056577A1 (en) 2010-03-04
TWI473798B (zh) 2015-02-21
IL211335A (en) 2013-12-31
AU2009284867A2 (en) 2011-04-21
CN102197033A (zh) 2011-09-21
TW201010993A (en) 2010-03-16
GEP20135786B (en) 2013-03-11
AU2009284867A1 (en) 2010-03-04
PE20110300A1 (es) 2011-06-16
RS52872B (sr) 2013-12-31
CA2735162A1 (en) 2010-03-04
ME01598B (me) 2014-09-20
CA2735162C (en) 2015-06-23
CL2011000402A1 (es) 2011-07-29
DK2318390T3 (da) 2013-07-08
BRPI0917705A2 (pt) 2016-02-16

Similar Documents

Publication Publication Date Title
UA105185C2 (uk) Піроли
MY177250A (en) Novel nicotinamide derivative or salt thereof
MX2009008465A (es) Nuevas 2-aminooxazolinas como ligandos de taar1.
MD20110063A2 (en) Herbicidal compositions containing benzoylpyrazole compounds
WO2008108378A3 (en) Bicyclic oxomorpholine derivative
MX2009004920A (es) Nuevos derivados de aminopirimidina como inhibidores de plk1.
MY153910A (en) BICYCLIC y-AMINO ACID DERIVATIVE
MY158982A (en) Heterocyclic compound
TW200626559A (en) Anilino-pyrimidine analogs
TN2011000053A1 (en) Organic compounds
EA201290401A1 (ru) Азотсодержащее гетероциклическое соединение и сельскохозяйственный фунгицид
MY150778A (en) Fused heterocyclic compound
MX2010004493A (es) Compuestos de tropano.
IN2014CN00613A (enExample)
MY169179A (en) Novel piperidine compound or salt thereof
ZA201002139B (en) New compounds as adenosine a1 receptor antagonists
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии
MY160882A (en) Biocidal composition and method
MX2013005753A (es) Nuevos derivados de biaril amida.
PH12013501856A1 (en) Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these
PH12013500443A1 (en) Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine.
MY161992A (en) Novel tetrahydroisoquinoline derivative
EA200700360A1 (ru) Новые производные амида гетероциклической карбоновой кислоты
IN2013MN00506A (enExample)
MX2013015376A (es) Heterociclicos microbiocidas.